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What's new  
Date / Event Description 
History  
Date / Event Description 
Abstract  
Background  
Blood for transfusion may become contaminated at any point between 
collection and transfusion and may result in bacteraemia (the presence of 
bacteria in the blood), severe illness or even death for the blood recipient. 
Donor arm skin is one potential source of blood contamination, so it is 
usual to cleanse the skin with an antiseptic before blood donation. One-
step and two-step alcohol based antiseptic regimens are both commonly 
advocated but there is uncertainty as to which is most effective. 
Objectives  
To assess the effects of cleansing the skin of blood donors with alcohol in a 
one-step compared with alcohol in a two-step procedure to prevent 
contamination of collected blood or bacteraemia in the recipient. 
Search methods  
We searched the Cochrane Wounds Group Specialised Register (March 10 
2009); The Cochrane Central Register of Controlled Trials (CENTRAL) The 
Cochrane Library 2009, Issue 1; Ovid MEDLINE - (1950 to February Week 
4 2009); Ovid EMBASE - (1980 to 2009 Week 9); and EBSCO CINAHL - 
(1982 to February Week 4 2009). We also searched the reference lists of 
key papers. 
Selection criteria  
All randomised trials (RCTs) comparing alcohol based donor skin cleansing 
in a one-step versus a two-step process that includes alcohol and any other 
antiseptic for pre-venepuncture skin cleansing were considered. Quasi 
randomised trials were to have been considered in the absence of RCTs. 
Data collection and analysis  
Two review authors independently assessed studies for inclusion. 
Results  
No studies (RCTs or quasi RCTs) met the inclusion criteria. 
Authors' conclusions  
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We did not identify any eligible studies for inclusion in this review. It is 
therefore unclear whether a two-step, alcohol followed by antiseptic skin 
cleansing process prior to blood donation confers any reduction in the risk 
of blood contamination or bacteraemia in blood recipients, or conversely 
whether a one-step process increases risk above that associated with a 
two-step process.  
Plain language summary  
Alcohol, with or without an antiseptic, for preparing 
the skin before blood collection, to prevent 
bacteraemia or contamination of blood for 
transfusion. 
  
When blood is collected from blood donors for transfusion it may become 
contaminated during collection, storage or transfusion. Blood contamination 
can cause bacteraemia (the presence of bacteria in the blood), severe 
illness or even death in the blood recipient. When blood is being taken from 
donors, the skin on the arm of the donor is one potential source of 
contamination, so it is usual to cleanse the arm with an antiseptic first, and 
both one-step and two-step alcohol based regimens are commonly used, 
however there is uncertainty about which regimen is the most effective for 
reducing the microbial load (the number of microscopic bacterial 
organisms) on the donor arm. We looked for studies that compared the use 
of alcohol alone versus the use of alcohol followed by another antiseptic to 
clean the arm before the needle is inserted to draw blood, but we did not 
find any relevant studies. It is currently unclear whether donor skin 
cleansing with a one-step alcohol based regimen reduces the risk of blood 
contamination compared with a two-step alcohol based regimen during 
blood donation. 
Background  
Complications associated with the infusion of blood and blood-related 
products have reduced in recent years, due to considerable advances in 
detecting transfusion-related viral pathogens, such as human 
immunodeficiency virus (HIV) and hepatitis C and B virus (HCV and HBV). 
In contrast, bacteraemia, resulting from bacterial contamination of blood 
products continues to be an ongoing problem (Sandler 2003; Wagner 
2004). Exogenous contamination of donor blood may occur at any point 
during collection, storage and transfusion (McDonald 2001). One of the 
sources of contamination is thought to be the donor's skin, as a result of 
inadequate skin cleansing (de Korte 2006; McDonald 2006). 
Description of the condition  
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Bacteraemia, or the presence of bacteria in the blood, is a potentially fatal 
condition. It is associated with high rates of morbidity (Hakim 2007; Sligl 
2006). Microorganisms may enter the blood stream through almost any 
organ (for example the lungs following pneumonia), through a surgical site, 
or via an implanted device such as an intravenous catheter. Prognosis is 
related to the virulence of the infective organism, severity of the sepsis at 
diagnosis and the underlying health of the patient (Herchline 1997). 
Although the aetiology of bacteraemia is often difficult to identify, 
transfusion-transmitted infection is a rare cause. The incidence of bacterial 
transmission through donated blood is estimated at between 1 per 100,000 
and 1 per 1,000,000 units for packed red blood cells, and between 1 per 
900 and 1 per 100,000 units for platelets (Walther-Wenke 2008). Fatalities 
are associated with 1 in 8,000,000 red cell units and 1 in 50,000 to 500,000 
white cell units (Wagner 2004). The reason for higher rates in platelet 
transfusion is thought to be because frozen platelets are thawed and stored 
at room temperature before infusion and if they are not used immediately 
there is an opportunity for any organisms that may be present to multiply 
before the product is transfused. Further reduction of infection rates 
depends on ensuring that blood for transfusion is free of contaminants. One 
way of achieving this is through careful preparation and cleansing of the 
donor's skin at the collection site. 
Description of the intervention  
There is no standard method for cleansing the site on the blood donor's 
skin from which the blood will be taken (generally the cubital fossa, or the 
inner aspect of the elbow). However, alcohol, followed by an application of 
povidone iodine has been traditionally used (Shahar 1990; Kiyoyama 
2009). Consequently, the interventions of interest for this review are skin 
cleansing with alcohol (usually 70% isopropyl alcohol) for skin preparation 
in a one-step process, compared with a two-step process involving alcohol 
followed by povidone iodine or other antiseptic solution. Antiseptics are 
antimicrobial substances that are applied to living tissue or skin to reduce 
the possibility of infection, sepsis or putrefaction. They should generally be 
distinguished from antibiotics that destroy bacteria within the body, and 
from disinfectants, which destroy microorganisms found on non-living 
objects. Alcohol is widely used prior to venepuncture and is available from 
a number of manufacturers as easy-to-use disinfection wipes. Isopropyl 
alcohol is a flammable, colourless liquid; also known as 2-propanol (MSDS 
2006). 
How the intervention might work  
Alcohol kills most bacteria and fungi by acting on lipid and protein 
components of the cell. It is less effective against viruses (Adams 2007). 
Isopropyl alcohol has some advantages over other products because it 
requires a shorter contact time to achieve antisepsis. For example some 
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two-step procedures take up to two minutes to perform, which is 
considered too long for some blood bank services (McDonald 2006). 
Antiseptics are toxic to living tissues as well as bacterial cells, some 
antiseptics are true germicides, capable of destroying microbes 
(bacteriocidal), whilst others are bacteriostatic and only prevent or inhibit 
their growth (Morgan 1993).  
Why it is important to do this review  
Although a range of antiseptics has been used to cleanse the skin of the 
donor arm, a two-step process, including alcohol and iodine is widely used 
(Shahar 1990; Kiyoyama 2009). The effectiveness of this regimen, and 
other forms of cleansing has been evaluated in a number of studies by 
measuring the microbial load on the donor arm (Cid 2003; Follea 1997; 
Goldman 1997; McDonald 2001; Wong 2004) and any contamination of 
platelet concentrates de Korte 2006; Lee 2002) however it remains unclear 
whether isopropyl alcohol alone is as effective as alcohol plus povidone 
iodine (or any other antiseptic) in preventing the clinical consequences of 
contaminated blood. This review question was brought to us by the World 
Health Organisation (WHO) and a scoping search did not identify any 
existing systematic review which had previously addressed this question. 
Objectives  
To assess the effects of cleansing the donor arm with alcohol in a one-step 
regimen compared with a two-step regimen including alcohol followed by 
any other antiseptic to prevent donor blood contamination or recipient 
bacteraemia. 
Methods  
Criteria for considering studies for this review  
Types of studies  
All randomised controlled trials (RCTs) comparing a one-step alcohol 
regimen with any two-step regimen that includes alcohol followed by 
another antiseptic for pre-venepuncture skin cleansing were considered. 
Cluster randomised trials and crossover trials were also eligible for 
inclusion. Quasi randomised trials were to have been considered in the 
absence of RCTs. 
Types of participants  
Studies enrolling people of any age and in any setting, having 
venepuncture and blood collection were eligible, irrespective of whether the 
venepuncture was for the purpose of blood donation. Studies should also 
include follow up from the recipients of the donated blood in order to 
measure outcomes occurring in the recipient. 
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Types of interventions  
Studies which compared one-step donor skin cleansing with alcohol (any 
concentration or application method) with a two-step method which 
involved alcohol (any strength or application method) followed by any other 
antiseptic (any concentration or application method) were eligible. 
Types of outcome measures  
At least one of the primary outcomes was to have been reported for the 
study to be considered for inclusion in the review. 
Primary outcomes  
• Bacteraemia in the blood recipient (the presence of bacteria in the blood 
stream) as measured by blood culture.  
• Blood product contamination (blood products include whole blood, 
platelets, red blood cells or any other product derived from the blood 
collection) at any time between collection and transfusion as detected 
most commonly by blood culture. 
Proxy outcome measures, such as skin contamination or skin colonisation, 
were not considered for several reasons. Namely, any antiseptic will reduce 
levels of microflora on the skin and swabbing skin for bacteria is really a 
'sampling procedure' which is subject to inconsistencies in sampling. In 
addition, a positive skin culture does not automatically mean that the blood 
collected for transfusion will be positive for bacteria (in the same way that a 
positive skin culture before surgery does not mean the person will develop 
a surgical site infection). 
Secondary outcomes  
• Death of the blood recipient, attributed to the transfusion.  
• Any adverse effects in the blood recipient associated with the transfusion. 
This may include sepsis (a grouping of signs such as fever, chills, or 
hypotension), septic shock (severe disturbances of temperature, 
respiration, heart rate or white blood cell count) or multiple organ 
dysfunction syndrome (altered organ function in a severely ill patient that 
requires medical intervention to prevent death). 
Search methods for identification of studies  
Electronic searches  
We searched the following databases: 
• Cochrane Wounds Group Specialised Register (Searched March 10 
2009);  
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• The Cochrane Central Register of Controlled Trials (CENTRAL) -The 
Cochrane Library 2009, Issue 1;  
• Ovid MEDLINE - 1950 to February Week 4 2009;  
• Ovid EMBASE - 1980 to 2009 Week 9;  
• EBSCO CINAHL - 1982 to February Week 4 2009. 
The Cochrane Central Register of Controlled Trials (CENTRAL) was 
searched using the following strategy: 
#1 MeSH descriptor Blood Specimen Collection explode all trees 
#2 MeSH descriptor Blood Transfusion explode all trees 
#3 MeSH descriptor Blood Donors explode all trees 
#4 (blood NEXT collection*) or (blood NEXT donor*) or (blood NEXT 
donation*):ti,ab,kw 
#5 (collection NEAR/1 blood) or (donation NEAR/1 blood):ti,ab,kw 
#6 ven*puncture NEXT site*:ti,ab,kw 
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6) 
#8 MeSH descriptor Antisepsis explode all trees 
#9 MeSH descriptor Anti-Infective Agents, Local explode all trees 
#10 MeSH descriptor Iodine Compounds explode all trees 
#11 MeSH descriptor Povidone-Iodine explode all trees 
#12 MeSH descriptor Alcohols explode all trees 
#13 MeSH descriptor Disinfectants explode all trees 
#14 MeSH descriptor Disinfection explode all trees 
#15 skin NEXT preparation:ti,ab,kw 
#16 disinfect*:ti,ab,kw 
#17 (“alcohol” or “alcohols” or iodine or povidone-iodine or 
chlorhexidine):ti,ab,kw 
#18 (#8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 
OR #17) 
#19 (#7 AND #18) 
The search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO 
CINAHL can be found in Appendix 2, Appendix 3 and Appendix 4 
respectively. The Ovid MEDLINE search was combined with the Cochrane 
Highly Sensitive Search Strategy for identifying randomised trials in 
MEDLINE: sensitivity- and precision-maximizing version (2008 revision) 
(Lefebvre 2008). The Ovid EMBASE and EBSCO CINAHL searches were 
combined with the trial filters developed by the Scottish Intercollegiate 
Guidelines Network (SIGN 2009). There was no restriction on the basis of 
date or language of publication. 
Searching other resources  
Reference lists of articles retrieved in full were searched. 
Data collection and analysis  
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Selection of studies  
Titles and abstracts identified through the search process were 
independently reviewed by two review authors. Full reports of all potentially 
relevant studies were retrieved for further assessment of eligibility based on 
the inclusion criteria. Differences of opinion were settled by consensus or 
referral to a third review author. There was no blinding to study authorship 
when we did these assessments. 
Data extraction and management  
We had planned to extract the following data, where available (to be 
extracted by one review author and checked by a second review author): 
• details of the trial/study (first author, year of publication, journal, 
publication status, period);  
• setting and country of study;  
• source of funding;  
• inclusion and exclusion criteria;  
• baseline characteristics of participants (age, sex);  
• aspects of morbidity of the blood recipients, e.g. predictors of susceptibility 
to bacteraemia;  
• number of participants in each arm of the trial;  
• description of intervention (type, duration);  
• description of control intervention (type, duration);  
• details and duration of follow up;  
• primary and secondary outcomes (by group);  
• design / methodological quality data as per risk of bias criteria;  
• unit of randomisation (where relevant);  
• unit of analysis;  
• results and primary statistical  analysis. 
Assessment of risk of bias in included studies  
Two review authors were to independently assess study risk of bias using 
the Cochrane Collaboration tool (Higgins 2008a).This tool addresses six 
specific domains, namely sequence generation, allocation concealment, 
blinding, incomplete outcome data, selective outcome reporting and other 
issues (e.g. co-interventions)(see Appendix 1 for details of criteria on which 
the judgements were to have been based). Blinding and completeness of 
outcome data would have been assessed for each outcome separately and 
we had planned to complete a risk of bias table for each eligible study. 
We planned to contact investigators of included studies to resolve any 
ambiguities. We also planned to include data from duplicate publications 
only once, but to retrieve all publications pertaining to a single study to 
enable full data extraction and risk of bias quality assessment. 
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For any eligible study, we planned to present assessment of risk of bias 
using a 'risk of bias summary figure', which presents the judgments in a 
cross-tabulation of study by entry. This display of internal validity indicates 
the weight the reader may give the results of each study. 
Measures of treatment effect  
For individual trials, effect measures for categorical outcomes (e.g. rates of 
bacteraemia) would have included relative risk (RR) with its 95% 
confidence interval (CI). For continuous outcomes, we planned to use the 
mean difference (MD) or, if the scale of measurement differed across trials, 
standardized mean difference (SMD), each with its 95% CI. For any meta-
analyses (see below), for categorical outcomes the typical estimates of RR 
with their 95% CI would have been calculated; and for continuous 
outcomes the weighted mean difference (WMD) or a summary estimate for 
SMD, each with its 95% CI, would have been calculated. 
We planned to analyse data using The Cochrane Collaboration's Review 
Manager 5 software. 
Dealing with missing data  
If outcome data had remained missing despite our attempts to obtain 
complete outcome data from authors, we would have performed an 
available-case analysis, based on the numbers of patients for whom 
outcome data were known. If standard deviations were missing, we would 
have imputed them from other studies or, where possible, computed them 
from standard errors using the formula SD = SE x √¯N , where these were 
available (Higgins 2008b). 
Assessment of heterogeneity  
Heterogeneity would have been assessed visually and by using the chi-
squared statistic with significance being set at p < 0.10. In addition, the 
degree of heterogeneity would have been investigated by calculating the I2 
statistic (Deeks 2008). If evidence of significant heterogeneity had been 
identified (I2 >50%), we would have explored potential causes and a 
random-effects approach to the analysis would have been used if a meta-
analysis had been appropriate. 
Assessment of reporting biases  
Reporting bias would have been assessed using guidelines in the 
Cochrane Handbook for Systematic Reviews of Interventions (Sterne 
2008). 
Data synthesis  
Where appropriate, results of comparable trials would have been pooled 
and the pooled estimate together with its 95% CI would have been 
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reported. We planned to conduct a narrative review of eligible studies if 
statistical synthesis of data from more than one study was not possible or 
considered not appropriate. 
Subgroup analysis and investigation of 
heterogeneity  
We planned to analyse potential sources of heterogeneity using the 
following subgroup analysis: concealment of allocation (adequate versus 
not reported).  
Sensitivity analysis  
We planned to undertake a sensitivity analysis to explore the effect of 
excluding studies where concealment of allocation was unclear 
Results  
Description of studies  
We did not find any randomised or quasi-randomised controlled trials that 
met the inclusion criteria. 
Results of the search  
Our initial search identified 457 citations of which 19 were considered 
potentially relevant. Full copies of these papers were obtained and 
reviewed independently by two review authors, however, none met the 
inclusion criteria. 
Included studies  
No studies were included. 
Excluded studies  
The Table: Characteristics of excluded studies contains reasons for 
excluding 19 potentially eligible studies. In summary, two citations were for 
unsystematic literature reviews (Blajchman 2004; Wendel 2002) eight trials 
did not compare the eligible interventions (Calfee 2002; Choudhuri 1990; 
Little 1999; Mimoz 1999; Schifman 1993; Sutton 1999; Suwanpimolkul 
2008; Trautner 2002). Eight studies were not randomised or quasi 
randomised controlled trials (Kiyoyama 2009; de Korte 2006; Goldman 
1997; Lee 2002; McDonald 2006; Pleasant 1994 Shahar 1990; Wong 
2004). One study examined techniques for quantifying bacterial reduction 
(Follea 1997). 
Risk of bias in included studies  
No studies were included. 
Effects of interventions  
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We did not identify any eligible randomised or quasi randomised controlled 
trials, nor were we able to identify any ongoing trials. 
Discussion  
We have been unable to identify any trials addressing the effectiveness of 
alcohol alone compared with alcohol followed by any other antiseptic to 
prevent bacteraemia from transfused blood or blood products. This may be 
because infusion related bacteraemia is a relatively rare event and very 
large trials would be needed to investigate the effect of donor-arm 
cleansing. Sepsis rates for platelet transfusions are around 1:50,000 and 
for red cell transfusions around 1:500,000 (Sandler 2003). Therefore 
mounting a trial large enough to detect differences in clinical outcomes, 
based on products used for arm cleansing, would be prohibitively 
expensive and lengthy. 
Because of this, surrogate measures, such as contamination of stored 
blood have been used to evaluate antisepsis efficacy. However, again, we 
found no trials that compared alcohol alone with alcohol followed by any 
other antiseptic for cleansing the donor skin. A number of studies used the 
surrogate outcome of post-cleansing skin microbial load at the 
venepuncture site however we excluded such studies a priori on the 
grounds that this is a surrogate outcome of unproven validity; it is not 
known how skin contamination relates to blood recipient outcomes. 
Moreover none of these trials compared a one-step with a two-step 
cleansing process (de Korte 2006; Follea 1997; Goldman 1997). 
Whilst we did identify two studies that compared the effects of the eligible 
interventions they were otherwise ineligible for important methodological 
reasons and did not meet our pre-specified study design eligibility criteria. 
The first compared blood culture contamination following pre-venepuncture 
cleansing with 70% alcohol for one minute followed by povidone iodine 
solution for an additional minute with brief swabbing of the skin three to five 
times with 70% alcohol. Patients who were suspected of having 
bacteraemia had two blood samples taken; once using the two-step 
method and once with the standard method. Unfortunately it appeared from 
the report that the order in which the methods were used was not 
randomised and samples may have been taken from the same or a closely 
adjacent site with an unreported time lapse between sampling. Of the 181 
cultures tested in each group, eight (4.4%) were positive in the two-step 
group compared with six (3.3%) in the one-step preparation group (no 
statistically significant difference) (Shahar 1990). The second study 
potentially suffers from important selection bias in that the treatment groups 
were in different settings as well as receiving different modes of skin 
cleansing and compared blood culture contamination rates between 
patients in whom blood had been drawn in the emergency department and 
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who received a one-step 70% alcohol cleansing with inpatients who 
received a two-step 70% alcohol followed by povidone iodine procedure. 
Although there was a statistically significant difference in positive culture 
rates in favour of the one step process (189 (6.6%) positive cultures in the 
one-step group versus 248 (8.9%) in the two step, alcohol plus iodine 
group (p = 0.0015) (Kiyoyama 2009) this study was not eligible for inclusion 
in the review due to the inherent risk of selection bias (inpatients and 
emergency department patients may well be at different levels of risk of 
positive blood culture). Thus whilst the authors presented additional data to 
suggest that baseline positive blood culture rates were similar between 
inpatients and emergency department patients the risk of selection bias 
remains and this study was excluded (Kiyoyama 2009). 
In conclusion there is currently no evidence of a difference in either blood 
contamination or bacteraemia when donor skin is cleansed pre-
venepuncture with a one-step alcohol based process or a two-step alcohol 
plus antiseptic process. This lack of evidence for a difference however 
results from a complete absence of research and therefore a real difference 
cannot be discounted. Until better evidence emerges, decisions about 
which mode of pre-blood donation skin cleansing to use are likely to be 
driven by convenience and cost. It is also important to note that arm 
cleansing is only one of the points at which blood contamination may occur. 
Careful collection and storage of blood and blood products, and systematic 
surveillance to detect bacterial contamination can all contribute to the 
safety of patients requiring blood transfusions. Eliminating all bacteria from 
stored blood may not be possible. So, following relevant clinical guidelines 
(for example UK BTS Guidelines 2005) for collection and for detecting 
bacterial contamination in stored blood, both at the time of collection and at 
the time of issue, may be the most effective way of reducing infusion 
related bacteraemia (Yomtovian 2006). 
Summary of main results  
We did not identify any eligible studies for inclusion in this review. It is 
therefore unclear whether a two-step, alcohol followed by antiseptic skin 
cleansing process prior to blood donation confers any reduction in the risk 
of blood contamination or bacteraemia in blood recipients (or conversely 
whether a one-step process increases risk above that associated with a 
two-step process).  
Potential biases in the review process  
Biases in the review process were minimised as far as possible by 
adhering to the guidance provided by the Cochrane Handbook (Higgins 
2008). We believe that publication bias is unlikely in this case; whilst no 
trials met the inclusion criteria , this is probably due to the difficulty and 
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expense associated with mounting a trial large enough to answer the 
question. 
Authors' conclusions  
Implications for practice  
We did not find any eligible randomised or quasi randomised controlled 
trials. Until further research emerges, decisions about which mode of pre-
blood donation skin cleansing to use are likely to be driven by convenience 
and cost. It is also important to note that arm cleansing is only one of the 
points at which blood contamination may occur.  
Implications for research  
Cleansing the donor skin before taking blood for transfusion is important, 
but conducting a trial to compare the effects of using specific antiseptics on 
bacteraemia rates would be logistically difficult given the relatively rare 
event rate. It may be possible to estimate the effects of disinfecting with 
alcohol alone versus alcohol plus other antiseptics on blood contamination 
rates but this would still require very large sample sizes to detect clinically 
important differences. Alternatively, high quality observational studies may 
provide additional information to guide practice. A future comprehensive 
evidence synthesis that summarised the evidence for all competing 
alternative approaches to pre-blood donation skin cleansing would be 
worthwhile. 
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Characteristics of studies  
Characteristics of included studies  
Footnotes 
Characteristics of excluded studies  
Blajchman 2004  
Reason for 
exclusion Narrative, non-systematic literature review. 
Calfee 2002  
Reason for 
exclusion 
None of the four study arms involved a two-step skin 
preparation process. 
Choudhuri 1990  
Reason for 
exclusion 
Comparison of two one-step processes; alcohol swab 
compared with iodine swab. 
de Korte 2006  
Reason for 
exclusion 
Single arm study evaluating a double-swab isopropyl 
alcohol disinfection process. 
Follea 1997  
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Reason for 
exclusion 
Examined techniques for quantifying bacterial reduction 
by comparing a three-step process with no skin 
disinfection. 
Goldman 1997  
Reason for 
exclusion 
Abstract only available and it was unclear how patients 
where allocated to groups. Though this was not likely to 
have been randomised or quasi-randomised because 
one group was treated in a particular way on the basis 
that they were allergic to iodine. Also there was no one-
step, alcohol-only skin preparation group. 
Kiyoyama 2009  
Reason for 
exclusion 
Not a randomised or quasi-randomised controlled trial. 
Two independent groups were considered; one group 
from an inpatient ward was treated with isopropyl 
alcohol + povidone-iodine and the other from an 
emergency department was treated with isopropyl 
alcohol alone. 
Lee 2002  
Reason for 
exclusion 
Not a randomised or quasi-randomised controlled trial. 
Comparison of two two-step processes in consecutive 
time periods. Cetrimide/ chlorhexidine solution + 
isopropyl alcohol compared with povidone-iodine + 
isopropyl alcohol. 
Little 1999  
Reason for 
exclusion 
Povidone-iodine was compared with iodine tincture, i.e. 
not a comparison of a one-step with a two-step skin 
preparation. 
McDonald 2006  
Reason for 
exclusion 
An uncontrolled before and after evaluation of a two-
step process involving isopropyl alcohol + tincture of 
iodine. 
Mimoz 1999  
Reason for 
exclusion 
Povidone-iodine compared with chlorhexidine, i.e. not a 
comparison of a one-step with a two-step skin 
preparation. 
Pleasant 1994  
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Reason for 
exclusion 
Only available in abstract form; no information to 
suggest this was a randomised controlled trial; attempts 
to contact the authors were unsuccessful. 
Schifman 1993  
Reason for 
exclusion 
Comparison of two two-step processes, namely, 
isopropyl alcohol pads + povidone-iodine swabs 
compared with isopropyl alcohol/acetone scrub + 
povidone-iodine dispenser. 
Shahar 1990  
Reason for 
exclusion 
Not a randomised or quasi-randomised controlled trial; 
the venepuncture site was cleansed with a two-step 
process after which a culture was taken, at a later time 
point the venepuncture site was cleansed with a one-
step process after which a culture was taken. The two 
samples were collected from the same person but it is 
not clear from the report if the two venepuncture sites 
were different, if there was a possibility of cross 
contamination between sites and what time period 
separated the sampling process. 
Sutton 1999  
Reason for 
exclusion 
Isopropyl alcohol (IPA) compared with no IPA skin 
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Appendices  
1 Criteria for a judgment of 'yes' for the sources of 
bias  
1. Was the allocation sequence randomly generated? 
Yes, low risk of bias 
A random (unpredictable) assignment sequence. 
Examples of adequate methods of sequence generation are computer-
generated random sequence, coin toss (for studies with two groups), rolling 
a dice (for studies with two or more groups), drawing of balls of different 
colours, dealing previously shuffled cards. 
No, high risk of bias 
- Quasi-randomised approach: Examples of inadequate methods are: 
alternation, birth date, social insurance/security number, date in which they 
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are invited to participate in the study, and hospital registration number 
- Non-random approaches: Allocation by judgement of the clinician; by 
preference of the participant; based on the results of a laboratory test or a 
series of tests; by availability of the intervention. 
Unclear 
Insufficient information about the sequence generation process to permit 
judgement 
2. Was the treatment allocation adequately concealed? 
Yes, low risk of bias 
Assignment must be generated independently by a person not responsible 
for determining the eligibility of the participants. This person has no 
information about the persons included in the trial and has no influence on 
the assignment sequence or on the decision about whether the person is 
eligible to enter the trial. Examples of adequate methods of allocation 
concealment are: Central allocation, including telephone, web-based, and 
pharmacy controlled,randomisation; sequentially numbered drug containers 
of identical appearance; sequentially numbered, opaque, sealed 
envelopes. 
No, high risk of bias 
Examples of inadequate methods of allocation concealment are: alternate 
medical record numbers, unsealed envelopes; date of birth; case record 
number; alternation or rotation; an open list of random numbers any 
information in the study that indicated that investigators or participants 
could influence the intervention group. 
Unclear 
Randomisation stated but no information on method of allocation used is 
available. 
 3. Blinding was knowledge of the allocated interventions adequately 
prevented during the study?  
Was the participant blinded to the intervention? 
Yes, low risk of bias 
The treatment and control groups are indistinguishable for the participants 
or if the participant was described as blinded and the method of blinding 
was described. 
No, high risk of bias 
- Blinding of study participants attempted, but likely that the blinding could 
have been broken;  participants  were not blinded, and the nonblinding of 
others likely to introduce bias. 
Unclear 
Was the care provider blinded to the intervention? 
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Yes, low risk of bias 
The treatment and control groups are indistinguishable for the 
care/treatment providers or if the care provider was described as blinded 
and the method of blinding was described. 
No, high risk of bias 
Blinding of care/treatment providers attempted, but likely that the blinding 
could have been broken; care/treatment providers  were not blinded, and 
the nonblinding of others likely to introduce bias. 
Unclear  
Was the outcome assessor blinded to the intervention? 
Yes, low risk of bias 
Adequacy of blinding should be assessed for the primary outcomes.  The 
outcome assessor was described as blinded and the method of blinding 
was described. 
No, high risk of bias 
No blinding or incomplete blinding, and the outcome or outcome 
measurement is likely to be influenced by lack of blinding 
Unclear  
4. Were incomplete outcome data adequately addressed?  
Was the drop-out rate described and acceptable? 
The number of participants who were included in the study but did not 
complete the observation period or were not included in the analysis must 
be described and reasons given. 
Yes, low risk of bias 
If the percentage of withdrawals and drop-outs does not exceed 20% for 
short-term follow-up and 30% for long-term follow-up and does not lead to 
substantial bias. (N.B. these percentages are arbitrary, not supported by 
literature); 
No missing outcome data; 
Reasons for missing outcome data unlikely to be related to true outcome 
(for survival data, censoring unlikely to be introducing bias); 
Missing outcome data balanced in numbers across intervention groups, 
with similar reasons for missing data across groups; 
Missing data have been imputed using appropriate methods. 
No, high risk of bias 
Reason for missing outcome data likely to be related to true outcome, with 
either imbalance in numbers or reasons for missing data across 
intervention groups; 
Unclear 
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 Were all randomised participants analysed in the group to which they were 
allocated? (ITT analysis) 
Yes, low risk of bias 
Specifically reported by authors that ITT was undertaken and this was 
confirmed on study assessment, or not stated but evident from study 
assessment that all randomised participants are reported/analysed in the 
group they were allocated to for the most important time point of outcome 
measurement (minus missing values) irrespective of non-compliance and 
co-interventions. 
No, high risk of bias 
Lack of ITT confirmed on study assessment (patients who were 
randomised were not included in the analysis because they did not receive 
the study intervention, they withdrew from the study or were not included 
because of protocol violation) regardless of whether ITT reported or not 
‘As-treated’ analysis done with substantial departure of the intervention 
received from that assigned at randomisation; potentially inappropriate 
application of simple imputation. 
Unclear 
Described as ITT analysis, but unable to confirm on study assessment, or 
not reported and unable to confirm by study assessment. 
 5. Are reports of the study free of suggestion of selective outcome 
reporting? 
Yes, low risk of bias 
If all the results from all pre-specified outcomes have been adequately 
reported in the published report of the trial.  This information is either 
obtained by comparing the protocol and the final trial report, or in the 
absence of the protocol, assessing that the published report includes 
enough information to make this judgment. Alternatively a judgement could 
be made if the trial report lists the outcomes of interest in the methods of 
the trial and then reports all these outcomes in the results section of the 
trial report. 
No, high risk of bias 
Not all of the study’s pre-specified primary outcomes have been reported; 
One or more primary outcomes is reported using measurements, analysis 
methods or subsets of the data (e.g. sub scales) that were not prespecified; 
One or more reported primary outcomes were not pre-specified (unless 
clear justification for their reporting is provided, such as an unexpected 
adverse effect); 
One or more outcomes of interest in the review are reported incompletely 
so that they cannot be entered in a meta-analysis; 
The study report fails to include results for a key outcome that would be 
expected to have been reported for such a study. 
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Unclear 
 6. Other sources of potential bias:  
Were co-interventions avoided or similar? 
There were no co-interventions or there were co-interventions but they 
were similar between the treatment and control groups. 
 Was the compliance acceptable in all groups? 
The review author determines if the compliance with the interventions is 
acceptable, based on the reported intensity, duration, number and 
frequency of sessions for both the treatment intervention and control 
intervention(s). For example, ultrasound treatment is usually administered 
over several sessions; therefore it is necessary to assess how many 
sessions each participant attended or if participants completed the course 
of an oral drug therapy. For single-session interventions (for example: 
surgery), this item is irrelevant.  
2 Ovid MEDLINE search strategy  
1 exp Blood Specimen Collection/ 
2 exp Blood Transfusion/ 
3 exp Blood Donors/ 
4 (blood collection$ or blood donor$ or blood donation$).ti,ab. 
5 ((collect$ adj1 blood) or (donat$ adj1 blood)).ti,ab. 
6 ven?puncture site$.ti,ab. 
7 or/1-6 
8 exp Antisepsis/ 
9 exp Anti-Infective Agents, Local/ 
10 exp Iodine Compounds/ 
11 exp Povidone-Iodine/ 
12 exp Alcohols/ 
13 exp Disinfectants/ 
14 exp Disinfection/ 
15 skin preparation.ti,ab. 
16 disinfect$.ti,ab. 
17 (alcohol$1 or iodine or povidone-iodine or chlorhexidine).ti,ab. 
18 or/8-17 
19 7 and 18 
3 Ovid EMBASE search strategy  
1 exp Blood Sampling/ 
2 exp Blood Transfusion/ 
3 exp Blood Donor/ 
4 (blood collection$ or blood donor$ or blood donation$).ti,ab. 
5 ((collect$ adj1 blood) or (donat$ adj1 blood)).ti,ab. 
6 exp Vein Puncture/ 
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7 ven?puncture site$.ti,ab. 
8 or/1-7 
9 exp Antisepsis/ 
10 exp Topical Antiinfective Agent/ 
11 exp Iodine/ 
12 exp Povidone Iodine/ 
13 exp Chlorhexidine/ 
14 exp Alcohol/ 
15 exp Disinfectant Agent/ 
16 exp Disinfection/ 
17 skin preparation.ti,ab. 
18 disinfect$.ti,ab. 
19 (alcohol$1 or iodine or povidone-iodine or chlorhexidine).ti,ab. 
20 or/9-19 
21 8 and 20 
4 EBSCO CINAHL search strategy  
S19 S9 and S18 
S18 S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 
S17 TI ( alcohol or alcohols or iodine or povidone-iodine or chlorhexidine ) 
or AB ( alcohol or alcohols or iodine or povidone-iodine or chlorhexidine ) 
S16 TI disinfect* or AB disinfect* 
S15 TI skin preparation or AB skin preparation 
S14 (MH "Disinfectants") 
S13 (MH "Alcohols+") 
S12 (MH "Povidone-Iodine") 
S11 (MH "Iodine") 
S10 (MH "Antiinfective Agents, Local+") 
S9 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 
S8 TI venepuncture site* or AB venepuncture site* 
S7 (MH "Venipuncture+") 
S6 TI blood donation* or AB blood donation* 
S5 TI blood donor* or AB blood donor* 
S4 TI blood collection* or AB blood collection* 
S3 (MH "Blood Donors") 
S2 (MH "Blood Transfusion+") 
S1 (MH "Blood Specimen Collection+") 
5 Protocol for the review ready for submission 
March 2009  
The protocol for this review was completed and ready for submission in 
March 2009, the review being completed and ready for submission in April 
2009. As the protocol has not been previously published in the Cochrane 
Library it is appended below in full.  
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Skin preparation with alcohol versus alcohol 
followed by any antiseptic for preventing 
bacteraemia or contamination of blood for 
transfusion. 
Protocol information 
Authors 
Joan Webster1, Sally EM Bell-Syer2, Ruth Foxlee2 
1Centre for Clinical Nursing, Royal Brisbane and Women's Hospital, 
Herston, Australia 
2Department of Health Sciences, University of York, York, UK 
Background 
Complications associated with the infusion of blood and blood-related 
products have reduced in recent years, due to considerable advances in 
detecting transfusion-related viral pathogens, such as human 
immunodeficiency virus (HIV) and hepatitis C and B virus (HCV and HBV). 
In contrast, bacteraemia, resulting from bacterial contamination of blood 
products continues to be an ongoing problem (Sandler 2003; Wagner 
2004). Exogenous contamination may occur at any point during collection 
and storage (McDonald 2001). One of these sources is thought to be the 
donors arm, as a result of inadequate skin disinfection (de Korte 2006; 
McDonald 2006). 
Description of the condition 
Bacteraemia, or the presence of bacteria in the blood, is a potentially fatal 
condition and associated with high rates of morbidity (Hakim 2007; Sligl 
2006). Microorganisms may enter the blood stream through almost any 
organ (for example the lungs following pneumonia); through a surgical site, 
or via an implanted device such as an intravenous catheter. Prognosis is 
related to the virulence of the infective organism, severity of the sepsis at 
diagnosis and the underlying health of the patient (Herchline 1997). 
Although the aetiology of bacteraemia is often difficult to identify, 
transfusion-transmitted infection is a rare cause. The incidence of bacterial 
transmission through donated blood is estimated at between 1 per 100,000 
and 1 per 1,000,000 units for packed red blood cells and between 1 per 
900 and 1 per 100,000 units for platelets (Walther-Wenke 2008). Fatalities 
are associated with 1 in 8,000,000 red cell units and 1 in 50,000 to 500,000 
white cell units (Wagner 2004). Further reduction of these rates depends 
on ensuring that blood for transfusion is free of contaminants. One way of 
achieving this is through careful preparation and disinfection of the arm of 
the blood donor. 
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Description of the intervention 
There is no standard method for cleansing the site on the blood donor's 
skin from which the blood will be taken (generally the cubital fossa, or the 
inner aspect of the elbow). However, alcohol, followed by an application of 
povidone iodine has been traditionally used (Shahar 1990; Kiyoyama 
2009). Consequently, the interventions of interest for this review are skin 
cleansing with alcohol (usually 70% isopropyl alcohol) for skin preparation 
in a one-step process, compared with a two-step process involving alcohol 
followed by povidone iodine or other antiseptic solution. Antiseptics are 
antimicrobial substances that are applied to living tissue or skin to reduce 
the possibility of infection, sepsis or putrefaction. They should generally be 
distinguished from antibiotics that destroy bacteria within the body, and 
from disinfectants, which destroy microorganisms found on non-living 
objects. Alcohol is widely used for venepuncture and is available, from a 
number of manufacturers as easy-to-use disinfection wipes. Isopropyl 
alcohol is a flammable, colourless liquid; also know as 2-propanol (Safety 
(MSDS) data for 2-propanol accessed 3 March 2009). 
How the intervention might work 
Alcohol kills most bacteria and fungi by acting on lipid and protein 
components of the cell. It is less effective against viruses (Adams 2007). 
Isopropyl alcohol has some advantages over other products because it 
requires a shorter contact time for disinfection. For example some two-
stage disinfection procedures take up to two minutes to perform, which is 
considered too long for some blood bank services (McDonald 2006). 
Antiseptics are toxic to living tissues as well as bacterial cells, some 
antiseptics are true germicides, capable of destroying microbes 
(bacteriocidal), whilst others are bacteriostatic and only prevent or inhibit 
their growth (Morgan 1993). 
Why it is important to do this review 
Although a range of antiseptics have been used to disinfect the donor arm, 
a two-step process, including alcohol and iodine is widely used. The 
effectiveness of this process, and other forms of disinfection have been 
evaluated in a number of studies by measuring the microbial load on the 
donor arm (Cid 2003; Follea 1997; Goldman 1997; McDonald 2001; Wong 
2004) and any contamination of platelet concentrates de Korte 2006; Lee 
2002). Despite this, it remains unclear if isopropyl alcohol alone is as 
effective as alcohol plus povidone iodine in preventing blood product 
contamination or bacteraemia. This review question was brought to us by 
the World Health Organisation (WHO) and a scoping search did not identify 
any existing systematic review which had previously addressed this 
question. 
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Objectives 
To assess the effects of cleansing the donor arm with alcohol in a one-step 
regimen compared with a two-step regimen including alcohol followed by 
any other antiseptic to prevent donor blood contamination or recipient 
bacteraemia. 
Methods 
Criteria for considering studies for this review 
Types of studies 
All randomised controlled trials (RCTs) comparing a one-step alcohol 
regimen with any two-step regimen that includes alcohol followed by 
another antiseptic for pre-venepuncture skin cleansing will be considered. 
Cluster randomised trials and crossover trials will also be eligible for 
inclusion. Quasi randomised trials will be considered in the absence of 
RCTs. 
Types of participants 
Studies enrolling people of any age and in any setting, having 
venepuncture and blood collection will be eligible, irrespective of whether 
the venepuncture was for the purpose of blood donation. Studies should 
also include follow up from the recipients of the donated blood in order to 
measure outcomes occurring in the recipient. 
Types of interventions 
Studies which compare a one-step donor skin cleansing with alcohol (any 
concentration or application method) with a two-step method which 
involves alcohol (any strength or application method) followed by any other 
antiseptic (any concentration or application method) will be eligible. 
Types of outcome measures 
At least one of the primary outcomes must be reported for inclusion of the 
review. 
Primary outcomes 
• Bacteraemia in the blood recipient (the presence of bacteria in the blood 
stream) as measured by blood culture.  
• Blood product contamination (blood products include whole blood, 
platelets, red blood cells or any other product derived from the blood 
collection) at any time between collection and transfusion as detected 
most commonly by blood culture. 
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Proxy outcome measures, such as skin contamination or skin colonisation, 
will not be considered. 
Secondary outcomes 
• Death of the blood recipient, attributed to the transfusion.  
• Any adverse effects in the blood recipient associated with the transfusion. 
This may include sepsis (a grouping of signs such as fever, chills, or 
hypotension), septic shock (severe disturbances of temperature, 
respiration, heart rate or white blood cell count) or multiple organ 
dysfunction syndrome (altered organ function in a severely ill patient that 
requires medical intervention to prevent death). 
Search methods for identification of studies 
Electronic searches 
The following databases will be searched: 
Cochrane Wounds Group Specialised Register; 
The Cochrane Central Register of Controlled Trials (CENTRAL) latest 
issue; 
Ovid MEDLINE - 1950 to Current; 
Ovid EMBASE - 1980 to Current; 
EBSCO CINAHL - 1982 to Current. 
The Cochrane Central Register of Controlled Trials (CENTRAL) will also be 
searched (latest issue) using the following strategy: 
#1 MeSH descriptor Blood Specimen Collection explode all trees 
#2 MeSH descriptor Blood Transfusion, Autologous explode all trees 
#3 MeSH descriptor Blood Donors explode all trees 
#4 (blood NEXT collection*) or (blood NEXT donor*) or (blood NEXT 
donation*):ti,ab,kw 
#5 ven*puncture:ti,ab,kw 
#6 (#1 OR #2 OR #3 OR #4 OR #5) 
#7 MeSH descriptor Antisepsis explode all trees 
#8 MeSH descriptor Anti-Infective Agents, Local explode all trees 
#9 MeSH descriptor Iodine Compounds explode all trees 
#10 MeSH descriptor Povidone-Iodine explode all trees 
#11 MeSH descriptor Alcohols explode all trees 
#12 MeSH descriptor Disinfectants explode all trees 
#13 MeSH descriptor Disinfection explode all trees 
#14 skin NEXT preparation:ti,ab,kw 
#15 skin NEXT disinfection:ti,ab,kw 
#16 (“alcohol” or “alcohols” or iodine or povidone-iodine or 
chlorhexidine):ti,ab,kw 
#17 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 
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OR #16) 
#18 (#6 AND #17) 
This strategy will be adapted were appropriate for the other databases. The 
Ovid MEDLINE search will be combined with the Cochrane Highly 
Sensitive Search Strategy for identifying randomised trials in MEDLINE: 
sensitivity- and precision-maximizing version (2008 revision) (Lefebvre 
2008). The Ovid EMBASE and EBSCO CINAHL searches will be combined 
with the trial filters developed by the Scottish Intercollegiate Guidelines 
Network (SIGN 2009). There was no restriction on the basis of date or 
language of publication. 
Searching other resources 
Reference lists of potentially useful articles will also be searched. 
Data collection and analysis 
Selection of studies 
Titles and abstracts identified through the search process will be 
independently reviewed by two review authors. Full reports of all potentially 
relevant trials will be retrieved for further assessment of eligibility based on 
the inclusion criteria. Differences of opinion will be settled by consensus or 
referral to a third review author. There will be no blinding of authorship. 
Data extraction and management 
Two review authors will independently assess the quality of eligible trials, 
using the quality assessment criteria outlined below. Disagreements 
between review authors will be resolved by consensus or referral to a third 
review author. We will contact investigators of included trials to resolve any 
ambiguities. Whilst data from duplicate publications will be included only 
once, all publications pertaining to a single study will be retrieved and used 
to enable full data extraction and quality assessment. 
We will extract the following data, where possible: 
• details of the trial/study (first author, year of publication, journal, 
publication status, period);  
• setting and country of study;  
• source of funding;  
• inclusion and exclusion criteria;  
• baseline characteristics of participants (age, sex);  
• aspects of morbidity of the blood recipients, e.g. predictors of susceptibility 
to bacteraemia;  
• number of participants in each arm of the trial;  
• description of intervention (type, duration);  
• description of control intervention (type, duration);  
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• details and duration of follow up;  
• primary and secondary outcomes (by group);  
• design / methodological quality data as per risk of bias criteria;  
• unit of randomisation (where relevant);  
• unit of analysis;  
• results and primary statistical  analysis. 
Assessment of risk of bias in included studies 
Two authors will independently assess each included study using the 
Cochrane Collaboration tool for assessing risk of bias Higgins 2008. This 
tool addresses six specific domains, namely sequence generation, 
allocation concealment, blinding, incomplete outcome data, selective 
outcome reporting and other issues (e.g. co-interventions)(see Appendix 1 
for details of criteria on which the judgement will be based). Blinding and 
completeness of outcome data will be assessed for each outcome 
separately. We will complete a risk of bias table for each eligible study. We 
will discuss any disagreement amongst all authors to achieve a consensus. 
We will present assessment of risk of bias using a 'risk of bias summary 
figure', which presents all of the judgments in a cross-tabulation of study by 
entry. This display of internal validity indicates the weight the reader may 
give the results of each study. 
Measures of treatment effect 
For individual trials, effect measures for categorical outcomes will include 
relative risk (RR) with its 95% confidence interval (CI). For statistically 
significant effects, number needed to treat (NNT), or number needed to 
harm (NNH), will be calculated. For continuous outcomes, the effect 
measure will be mean difference (MD) or, if the scale of measurement 
differs across trials, standardized mean difference (SMD), each with its 
95% CI. For any meta-analyses (see below), for categorical outcomes the 
typical estimates of RR with their 95% CI will be calculated; and for 
continuous outcomes the weighted mean difference (WMD) or a summary 
estimate for SMD, each with its 95% CI, will be calculated. 
Data will be analysed using The Cochrane Collaboration's Review Manager 
5 software. 
Dealing with missing data 
If some outcome data remain missing despite our attempts to obtain 
complete outcome data from authors, we will perform an available-case 
analysis, based on the numbers of patients for whom outcome data are 
known. If standard deviations are missing, we will impute them from other 
studies or, where possible, compute them from standard errors using the 
formula SD = SE x ?¯N , where these are available (Higgins 2008). 
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Assessment of heterogeneity 
Heterogeneity will be assessed visually and by using the chi-squared 
statistic with significance being set at p < 0.10. In addition, the degree of 
heterogeneity will be investigated by calculating the I2 statistic Higgins 
2008. If evidence of significant heterogeneity is identified (>50%), we will 
explore potential causes and a random-effects approach to the analysis will 
be used if a meta analysis is appropriate. 
Assessment of reporting biases 
Reporting bias will be assessed using guidelines in Cochrane Handbook for 
Systematic Reviews of Interventions (Higgins 2008). 
Data synthesis 
Where appropriate, results of comparable trials will be pooled using a fixed-
effect model and the pooled estimate together with its 95% CI will be 
reported. We will conduct a narrative review of eligible studies where 
statistical synthesis of data from more than one study is not possible or 
considered not appropriate. 
Subgroup analysis and investigation of 
heterogeneity 
We plan to analyse potential sources of heterogeneity using the following 
subgroup analysis - concealment of allocation (adequate versus not 
reported). 
Sensitivity analysis 
We will perform a sensitivity analysis to explore the effect of concealment 
of allocation (adequate versus not reported). 
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Appendices 
1 Criteria for a judgment of 'yes' for the sources of 
bias 
1. Was the allocation sequence randomly generated?  
Yes, low risk of bias 
A random (unpredictable) assignment sequence. 
Examples of adequate methods of sequence generation are computer-
generated random sequence, coin toss (for studies with two groups), rolling 
a dice (for studies with two or more groups), drawing of balls of different 
colours, dealing previously shuffled cards. 
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No, high risk of bias 
- Quasi-randomised approach: Examples of inadequate methods are: 
alternation, birth date, social insurance/security number, date in which they 
are invited to participate in the study, and hospital registration number 
- Non-random approaches: Allocation by judgement of the clinician; by 
preference of the participant; based on the results of a laboratory test or a 
series of tests; by availability of the intervention. 
Unclear 
Insufficient information about the sequence generation process to permit 
judgement 
2. Was the treatment allocation adequately concealed?  
Yes, low risk of bias 
Assignment must be generated independently by a person not responsible 
for determining the eligibility of the participants. This person has no 
information about the persons included in the trial and has no influence on 
the assignment sequence or on the decision about whether the person is 
eligible to enter the trial. Examples of adequate methods of allocation 
concealment are: Central allocation, including telephone, web-based, and 
pharmacy controlled,randomization; sequentially numbered drug containers 
of identical appearance; sequentially numbered, opaque, sealed 
envelopes. 
No, high risk of bias 
Examples of inadequate methods of allocation concealment are: alternate 
medical record numbers, unsealed envelopes; date of birth; case record 
number; alternation or rotation; an open list of random numbers any 
information in the study that indicated that investigators or participants 
could influence the intervention group. 
Unclear 
Randomisation stated but no information on method of allocation used is 
available. 
  3. Blinding was knowledge of the allocated interventions adequately 
prevented during the study?  
Was the participant blinded to the intervention? 
Yes, low risk of bias 
The treatment and control groups are indistinguishable for the participants 
or if the participant was described as blinded and the method of blinding 
was described. 
No, high risk of bias 
- Blinding of study participants attempted, but likely that the blinding could 
have been broken;  participants  were not blinded, and the nonblinding of 
others likely to introduce bias. 
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Unclear 
Was the care provider blinded to the intervention? 
Yes, low risk of bias 
The treatment and control groups are indistinguishable for the 
care/treatment providers or if the care provider was described as blinded 
and the method of blinding was described. 
No, high risk of bias 
Blinding of care/treatment providers attempted, but likely that the blinding 
could have been broken; care/treatment providers  were not blinded, and 
the nonblinding of others likely to introduce bias. 
Unclear  
Was the outcome assessor blinded to the intervention? 
Yes, low risk of bias 
Adequacy of blinding should be assessed for the primary outcomes.  The 
outcome assessor was described as blinded and the method of blinding 
was described. 
No, high risk of bias 
No blinding or incomplete blinding, and the outcome or outcome 
measurement is likely to be influenced by lack of blinding 
Unclear  
4. Were incomplete outcome data adequately addressed?  
Was the drop-out rate described and acceptable? 
The number of participants who were included in the study but did not 
complete the observation period or were not included in the analysis must 
be described and reasons given. 
Yes, low risk of bias 
If the percentage of withdrawals and drop-outs does not exceed 20% for 
short-term follow-up and 30% for long-term follow-up and does not lead to 
substantial bias. (N.B. these percentages are arbitrary, not supported by 
literature); 
No missing outcome data; 
Reasons for missing outcome data unlikely to be related to true outcome 
(for survival data, censoring unlikely to be introducing bias); 
Missing outcome data balanced in numbers across intervention groups, 
with similar reasons for missing data across groups; 
Missing data have been imputed using appropriate methods. 
No, high risk of bias 
Reason for missing outcome data likely to be related to true outcome, with 
either imbalance in numbers or reasons for missing data across 
intervention groups; 
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Unclear 
 Were all randomised participants analysed in the group to which they were 
allocated? (ITT analysis) 
Yes, low risk of bias 
Specifically reported by authors that ITT was undertaken and this was 
confirmed on study assessment, or not stated but evident from study 
assessment that all randomised participants are reported/analysed in the 
group they were allocated to for the most important time point of outcome 
measurement (minus missing values) irrespective of non-compliance and 
co-interventions. 
No, high risk of bias 
Lack of ITT confirmed on study assessment (patients who were 
randomised were not included in the analysis because they did not receive 
the study intervention, they withdrew from the study or were not included 
because of protocol violation) regardless of whether ITT reported or not 
‘As-treated’ analysis done with substantial departure of the intervention 
received from that assigned at randomisation; potentially inappropriate 
application of simple imputation. 
Unclear 
Described as ITT analysis, but unable to confirm on study assessment, or 
not reported and unable to confirm by study assessment. 
  5. Are reports of the study free of suggestion of selective outcome 
reporting?  
Yes, low risk of bias 
If all the results from all pre-specified outcomes have been adequately 
reported in the published report of the trial.  This information is either 
obtained by comparing the protocol and the final trial report, or in the 
absence of the protocol, assessing that the published report includes 
enough information to make this judgment. Alternatively a judgement could 
be made if the trial report lists the outcomes of interest in the methods of 
the trial and then reports all these outcomes in the results section of the 
trial report. 
No, high risk of bias 
Not all of the study’s pre-specified primary outcomes have been reported; 
One or more primary outcomes is reported using measurements, analysis 
methods or subsets of the data (e.g. subscales) that were not prespecified; 
One or more reported primary outcomes were not pre-specified (unless 
clear justification for their reporting is provided, such as an unexpected 
adverse effect); 
One or more outcomes of interest in the review are reported incompletely 
so that they cannot be entered in a meta-analysis; 
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The study report fails to include results for a key outcome that would be 
expected to have been reported for such a study. 
Unclear 
  6. Other sources of potential bias:  
Were co-interventions avoided or similar? 
There were no co-interventions or there were co-interventions but they 
were similar between the treatment and control groups. 
 Was the compliance acceptable in all groups? 
The review author determines if the compliance with the interventions is 
acceptable, based on the reported intensity, duration, number and 
frequency of sessions for both the treatment intervention and control 
intervention(s). For example, ultrasound treatment is usually administered 
over several sessions; therefore it is necessary to assess how many 
sessions each participant attended or if participants completed the course 
of an oral drug therapy. For single-session interventions (for example: 
surgery), this item is irrelevant.  
 
